Yes, he should. However, a slip like that is important, IMO. They haven't seen the data but they have more insight into the info than we do. They have more contact with the data collectors and analysts than we do. Their conversations with lead doctors in the trial have been going on for 12yrs. It's a tell in my eyes.
LG also should not have said they will apply to those 4 countries.
Maybe UK, but that is not certain as of today. And Germany? What is he talking about? Germany is still in the EU last I heard and all cancer treatments go through the EMA.
Not his worst gaff though. He also asserted GBM is the biggest killer of all cancers. Not even close. Brain cancers as a whole do not even make the top 15.
Market Data 
Markets 
AI
